Suppr超能文献

按需治疗的甲型血友病患者注射凝血因子 VIII 后纤维蛋白凝块结构的改善

Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand.

作者信息

Antovic Aleksandra, Mikovic Danijela, Elezovic Ivo, Zabczyk Michael, Hutenby Kjell, Antovic Jovan P

机构信息

Aleksandra Antovic, Karolinska Institutet, Dept. of Clinical Sciences, Danderyd Hospital, 182 88 Stockholm, Sweden, Tel.: + 46 734294448, E-mail:

出版信息

Thromb Haemost. 2014 Apr 1;111(4):656-61. doi: 10.1160/TH13-06-0479. Epub 2013 Nov 21.

Abstract

Patients with haemophilia A have seriously impaired thrombin generation due to an inherited deficiency of factor (F)VIII, making them form unstable fibrin clots that are unable to maintain haemostasis. Data on fibrin structure in haemophilia patients remain limited. Fibrin permeability, assessed by a flow measurement technique, was investigated in plasma from 20 patients with severe haemophilia A treated on demand, before and 30 minutes after FVIII injection. The results were correlated with concentrations of fibrinogen, FVIII and thrombin-activatable fibrinolysis inhibitor (TAFI), and global haemostatic markers: endogenous thrombin potential (ETP) and overall haemostatic potential (OHP). Fibrin structure was visualised using scanning electron microscopy (SEM). The permeability coefficient Ks decreased significantly after FVIII treatment. Ks correlated significantly with FVIII levels and dosage, and with ETP, OHP and levels of TAFI. SEM images revealed irregular, porous fibrin clots composed of thick and short fibers before FVIII treatment. The clots had recovered after FVIII replacement almost to levels in control samples, revealing compact fibrin with smaller intrinsic pores. To the best of our knowledge, this is the first description of fibrin porosity and structure before and after FVIII treatment of selected haemophilia patients. It seems that thrombin generation is the main determinant of fibrin structure in haemophilic plasma.

摘要

甲型血友病患者由于遗传性因子(F)VIII缺乏,凝血酶生成严重受损,导致他们形成不稳定的纤维蛋白凝块,无法维持止血。血友病患者纤维蛋白结构的数据仍然有限。采用流动测量技术评估纤维蛋白通透性,对20例按需治疗的重度甲型血友病患者注射FVIII前及注射后30分钟的血浆进行了研究。结果与纤维蛋白原、FVIII和凝血酶激活的纤维蛋白溶解抑制剂(TAFI)浓度以及整体止血标志物:内源性凝血酶潜力(ETP)和整体止血潜力(OHP)相关。使用扫描电子显微镜(SEM)观察纤维蛋白结构。FVIII治疗后,通透系数Ks显著降低。Ks与FVIII水平和剂量、ETP、OHP以及TAFI水平显著相关。SEM图像显示,FVIII治疗前,纤维蛋白凝块不规则、多孔,由粗短纤维组成。FVIII替代治疗后,凝块几乎恢复到对照样本水平,显示出具有较小固有孔隙的致密纤维蛋白。据我们所知,这是首次对选定血友病患者FVIII治疗前后纤维蛋白孔隙率和结构的描述。凝血酶生成似乎是血友病血浆中纤维蛋白结构的主要决定因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验